Delivery Order SPE2DB22D6029-SPE2DB25FLSXM

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $129,142.84, is a firm fixed-price delivery order for the LUPRON DEPOT-PED 11.25 MG 3MOS medical product. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4565481076 units of Lupron Depot-Ped 11.25 mg 3-month medication. The fixed-price delivery order, valued at $78,154.24, has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to supply a wide range of critical medical...
This federal contract award is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS medication to the Defense Logistics Agency (DLA). The $86,491.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $97,785.07 Firm Fixed Price Delivery Order is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialized pharmaceutical product. The contract has a period of performance through November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,526.84 firm-fixed-price delivery order is for the procurement of LUPRON DEPOT-PED 30 MG 3MO KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the procurement of LUPRON DEPOT-PED 11.25 MG KITS, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $8,504.05 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,779.73, is for the delivery of the medication Lupron Depot-Ped 11.25 mg with a completion date of May 28, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,297.17 firm fixed-price contract is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a pediatric medication. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for LUPRON DEPOT-PED 11.25 MG 3MOS, a pharmaceutical product, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,417.38 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,736.48 firm-fixed-price contract is for the supply of Lupron Depot 3.75 mg kits, a specialty medication. The award has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLSXM
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $16,858.52 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product Lupron Depot-Ped 11.25 mg 3 months. The award has a completion date of October 30, 2024 and a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen holds significant IDCs with federal agencies like the DLA and Department of Justice, providing a wide range of critical medical commodities to support military, veterans, and other government healthcare programs.

Generated 5/20/25, 1:51 PM